First Wave BioPharma Statistics
Total Valuation
FWBI has a market cap or net worth of $5.75 million. The enterprise value is $2.83 million.
| Market Cap | 5.75M |
| Enterprise Value | 2.83M |
Important Dates
The next estimated earnings date is Tuesday, April 30, 2024, after market close.
| Earnings Date | Apr 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
FWBI has 2.03 million shares outstanding. The number of shares has increased by 836.57% in one year.
| Shares Outstanding | 2.03M |
| Shares Change (YoY) | +836.57% |
| Shares Change (QoQ) | -11.09% |
| Owned by Insiders (%) | 7.69% |
| Owned by Institutions (%) | 4.07% |
| Float | 1.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.58 |
| Quick Ratio | n/a |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -702.16 |
Financial Efficiency
Return on equity (ROE) is -614.80% and return on invested capital (ROIC) is -356.02%.
| Return on Equity (ROE) | -614.80% |
| Return on Assets (ROA) | -284.10% |
| Return on Capital (ROIC) | -356.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.79M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.11% in the last 52 weeks. The beta is 1.21, so FWBI's price volatility has been higher than the market average.
| Beta (1Y) | 1.21 |
| 52-Week Price Change | -94.11% |
| 50-Day Moving Average | 5.10 |
| 200-Day Moving Average | 7.03 |
| Relative Strength Index (RSI) | 27.86 |
| Average Volume (30 Days) | 119,574 |
Short Selling Information
The latest short interest is 55,041, so 2.72% of the outstanding shares have been sold short.
| Short Interest | 55,041 |
| Short Previous Month | 13,849 |
| Short % of Shares Out | 2.72% |
| Short % of Float | 2.88% |
| Short Ratio (days to cover) | 0.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.77M |
| Pretax Income | -15.79M |
| Net Income | -16.10M |
| EBITDA | -15.74M |
| EBIT | -15.77M |
| Earnings Per Share (EPS) | -$47.88 |
Balance Sheet
The company has $3.74 million in cash and $826,844 in debt, giving a net cash position of $2.92 million or $1.44 per share.
| Cash & Cash Equivalents | 3.74M |
| Total Debt | 826,844 |
| Net Cash | 2.92M |
| Net Cash Per Share | $1.44 |
| Equity / Book Value | 3.60M |
| Book Value Per Share | 1.78 |
| Working Capital | 1.82M |
Cash Flow
| Operating Cash Flow | -12.38M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.38M |
| FCF Per Share | -$36.80 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FWBI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -836.57% |
| Shareholder Yield | -836.57% |
| Earnings Yield | -279.98% |
| FCF Yield | -215.21% |
Analyst Forecast
The average price target for FWBI is $36.00, which is 1,167.61% higher than the current price. The consensus rating is "Buy".
| Price Target | $36.00 |
| Price Target Difference | 1,167.61% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 18, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Dec 18, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |